Skip to main content
. 2013 Feb 21;8(2):e57580. doi: 10.1371/journal.pone.0057580

Table 1. Reasons for not switching when first met immunological/clinical criteria for switch in patients receiving and not receiving CD4 monitoring.

CD4 monitoring (LCM) No CD4 monitoring (CDM)
Total met clinical (WHO 4 event) or immunological (confirmed CD4<100 cells/mm3) criteria for switch and either switched >8 weeks later or did not switch 132 (100%)
Total met clinical criteria (WHO 4 event) for switch and either switched >8 weeks later or did not switch 100 (100%)
Reason for not initially switching patient reported (details below)* 42 (32%) 44 (44%)
No reason reported but switched within 6 months 56 (42%) 33 (33%)
Reason not reported, not switched within 6 months 34 (26%) 23 (23%)
  Switched after 6 months 27 21
  Died or last seen alive and not switched 7 2
Reason for not switching when first met criteria (% of those reporting a reason) 42 (100%) 44 (100%)
Patient judged to be doing well 30 (71%) 20 (45%)
  CD4>200 19 N/A
  CD4 100-200 or <100 but still increasing 9 N/A
  only been on ART for ∼1 year 0 3
  clinical judgement that event not related to ART failure ** 2 12
  client felt well and did not want to switch 0 5
On TB treatment with rifampicin 10 (24%) 14 (32%)
Poor adherer/defaulter 1 (2%) 4 (9%)
Too ill to switch 0 (0%) 4 (9%)
Oversight: should have switched 1 (2%) 2 (5%)
*

based on a retrospective request for reasons why patients had not switched within 8 weeks of first meeting protocol switch criteria.

**

eg only presumptive diagnosis, responded to treatment for the clinical event, event judged related to recent period off ART, patient being monitored and doing well.